AGP Picks
View all

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 22, 2026

NONVERBAL ELLA 'SAYS YES TO THE DRESS'—AND 7 MILLION PEOPLE AGREE
UTRGV medical graduates carry nearly $72,000 less debt than public-school peers
Texas Tech University Health Sciences Center, UMC Health System Cancer Initiative Expands Treatment Options
Koda Health Announces Koda Compass, the Intelligence Engine Behind Every Goals-of-Care Conversation
HOCATT® and Genesis Regenerative Announce Strategic Partnership
Opterion Health gibt positive Ergebnisse der Phase-1-Studie für OPT101 bekannt, die den Übergang zur Phase 2a ermöglichen
オプテリオン・ヘルス、OPT101の第1相試験で、第2a相試験への移行を裏付ける良好な結果を発表
Opterion Health 宣布 OPT101 的 1 期临床试验结果积极,支持推进至 2a 期研究
Comfort Keepers Highlights Respite Care in Cedar Park, TX
Hyagen Medical Participates in PepMed 2026 to Discuss Regulatory Clarity in Stem Cell Therapy
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
MISTR to Fund 2 Million Free HIV & Hepatitis C Tests and Help States Save Hundreds of Millions in ADAP Costs
Voting Rights and Shares Capital of the Company
Information mensuelle relative au nombre total de droits de vote  et d’actions composant le capital social
Biomea Fusion Announces Proposed Public Offering of Securities
InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
Inkoop van eigen aandelen
Acquisition of Own Shares
IN8bio to Present at Sidoti Small-Cap Virtual Conference

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.